Hansoh Pharmaceutical Group Company Limited 3692.HK Stock
Hansoh Pharmaceutical Group Company Limited Price Chart
Hansoh Pharmaceutical Group Company Limited 3692.HK Financial and Trading Overview
Contents
- Hansoh Pharmaceutical Group Company Limited Price Chart
- Hansoh Pharmaceutical Group Company Limited 3692.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Hansoh Pharmaceutical Group Company Limited
- Q&A For Hansoh Pharmaceutical Group Company Limited Stock
| Hansoh Pharmaceutical Group Company Limited stock price | 16.2 HKD |
| Previous Close | 13.16 HKD |
| Open | 12.98 HKD |
| Bid | 13.44 HKD x N/A |
| Ask | 13.46 HKD x N/A |
| Day's Range | 12.98 - 13.6 HKD |
| 52 Week Range | 11.04 - 18.2 HKD |
| Volume | 3.79M HKD |
| Avg. Volume | 3.92M HKD |
| Market Cap | 79.86B HKD |
| Beta (5Y Monthly) | 0.636427 |
| PE Ratio (TTM) | 27.469387 |
| EPS (TTM) | 0.56 HKD |
| Forward Dividend & Yield | 0.19 (1.45%) |
| Ex-Dividend Date | June 5, 2023 |
| 1y Target Est | 19.66 HKD |
3692.HK Valuation Measures
| Enterprise Value | 60.65B HKD |
| Trailing P/E | 27.469387 |
| Forward P/E | 25.396229 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.51198 |
| Price/Book (mrq) | 3.5180345 |
| Enterprise Value/Revenue | 6.465 |
| Enterprise Value/EBITDA | 20.688 |
Trading Information
Hansoh Pharmaceutical Group Company Limited Stock Price History
| Beta (5Y Monthly) | 0.636427 |
| 52-Week Change | -0.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.2 HKD |
| 52 Week Low | 11.04 HKD |
| 50-Day Moving Average | 13.8 HKD |
| 200-Day Moving Average | 14.26 HKD |
3692.HK Share Statistics
| Avg. Volume (3 month) | 3.92M HKD |
| Avg. Daily Volume (10-Days) | 3.12M HKD |
| Shares Outstanding | 5.93B |
| Float | 1.08B |
| Short Ratio | N/A |
| % Held by Insiders | 81.76% |
| % Held by Institutions | 8.44% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.088 |
| Trailing Annual Dividend Yield | 0.66% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2779 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 27.53% |
| Operating Margin (ttm) | 27.79% |
| Gross Margin | 90.72% |
| EBITDA Margin | 31.24% |
Management Effectiveness
| Return on Assets (ttm) | 5.70% |
| Return on Equity (ttm) | 12.10% |
Income Statement
| Revenue (ttm) | 9.38B HKD |
| Revenue Per Share (ttm) | 1.59 HKD |
| Quarterly Revenue Growth (yoy) | -10.59% |
| Gross Profit (ttm) | 8.51B HKD |
| EBITDA | 2.93B HKD |
| Net Income Avi to Common (ttm) | 2.58B HKD |
| Diluted EPS (ttm) | 0.49 |
| Quarterly Earnings Growth (yoy) | -9.59% |
Balance Sheet
| Total Cash (mrq) | 21.63B HKD |
| Total Cash Per Share (mrq) | 3.65 HKD |
| Total Debt (mrq) | 4.38B HKD |
| Total Debt/Equity (mrq) | 19.33 HKD |
| Current Ratio (mrq) | 9.861 |
| Book Value Per Share (mrq) | 3.826 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.74B HKD |
| Levered Free Cash Flow (ttm) | 1.45B HKD |
Profile of Hansoh Pharmaceutical Group Company Limited
| Country | Hong Kong |
| State | N/A |
| City | Shanghai |
| Address | 287 Xiangke Road |
| ZIP | 201210 |
| Phone | 86 40 0828 5227 |
| Website | https://www.hspharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10523 |
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-tumor, anti-infectives, central nervous system diseases, metabolic diseases, and other therapeutic areas. Its principal products include Mailingda, Ameile, Hansoh Xinfu, Fulaimei, Hengmu, Xinwei, Tanneng, Ameining, Oulanning, Ailanning, Zetan, Ruibote, Fulaidi, Puruian, Fulairui, Pulaile, Zefei, Xinmei, Xintai, and Gainuo drugs, as well as XINYUE and Hengsen. The company serves pharmaceutical product distributors. It has a collaborations with NiKang Therapeutics to develop and commercialize NKT2152; TiumBio to develop and commercialize TU2670 for the treatment of endometriosis, uterine fibroids and other indications; Global Health Drug Discovery Institute to develop, manufacture, and commercialize the GDI-4405 series of anti-novel coronavirus; KiOmed Pharma SA to develop and commercialize KiOmedinevsOne for the treatment of osteoarthritis; and Biotheus Inc. to develop and commercialize PM1080. The company was founded in 1995 and is headquartered in Shanghai, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Q&A For Hansoh Pharmaceutical Group Company Limited Stock
What is a current 3692.HK stock price?
Hansoh Pharmaceutical Group Company Limited 3692.HK stock price today per share is 16.2 HKD.
How to purchase Hansoh Pharmaceutical Group Company Limited stock?
You can buy 3692.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hansoh Pharmaceutical Group Company Limited?
The stock symbol or ticker of Hansoh Pharmaceutical Group Company Limited is 3692.HK.
Which industry does the Hansoh Pharmaceutical Group Company Limited company belong to?
The Hansoh Pharmaceutical Group Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hansoh Pharmaceutical Group Company Limited have in circulation?
The max supply of Hansoh Pharmaceutical Group Company Limited shares is 5.93B.
What is Hansoh Pharmaceutical Group Company Limited Price to Earnings Ratio (PE Ratio)?
Hansoh Pharmaceutical Group Company Limited PE Ratio is 28.92857400 now.
What was Hansoh Pharmaceutical Group Company Limited earnings per share over the trailing 12 months (TTM)?
Hansoh Pharmaceutical Group Company Limited EPS is 0.56 HKD over the trailing 12 months.
Which sector does the Hansoh Pharmaceutical Group Company Limited company belong to?
The Hansoh Pharmaceutical Group Company Limited sector is Healthcare.
Hansoh Pharmaceutical Group Company Limited 3692.HK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| HANG SENG INDEX HSI | 16594.32 HKD 2121.79 USD |
-0.76
|
— — | 16465.4 HKD 2105.31 USD | 16636.15 HKD 2127.14 USD | — - | — — |
| HANG SENG COMMERCE & INDUSTRY HSNC | 9331.66 HKD 1193.17 USD |
-0.77
|
— — | 9236.87 HKD 1181.05 USD | 9354.57 HKD 1196.1 USD | — - | — — |
- {{ link.label }} {{link}}